MARKET WRAP: NZ shares rise on cow eradication

Harbour Asset Management analyst Shane Solly says

Harbour Asset Management analyst Shane Solly talks through the day on the markets.

0
0:00 0:10

New Zealand shares rose today, as the market had a muted response to the government’s decision to cull cow herds to eradicate the cattle disease Mycoplasma bovis.

The NZX50 index climbed 6.8 points to 8645.20, on turnover of $123 million.

Prime Minister Jacinda Ardern announced on Monday afternoon a plan of phased eradication which will cost about $886 million and cull all cattle on all infected properties.

“It’s good to see a decision being made but we’ll need to see more detail around that and communication,” says Harbour Asset Management analyst Shane Solly.

Since the disease was discovered in July last year, 11,000 cows have been slaughtered and just 4 of the 41 farms identified as infected have been cleared.

Under the plan announced today more than 150,000 cattle will be culled in a desperate bid to eradicate cattle disease.

Fonterra Co-operative shares fell 13c to $5.22 today while units in the Shareholders' Fund slipped 10c to $5.23.

A2 Milk fell 17c to $10.77, while Synlait Milk remained unchanged at $10.38. 

Fisher & Paykel Healthcare's record profit of $190.2m, up 12% on last year, failed to convince investors. The company's shares fell 17c to $13.18. 

Mr Solly says it was a strong result but the company’s forecast of $1.05 billion operating revenue in 2019 was “below market expectations.

“The result is reflecting some conservatism around F&P’s ongoing product launch and also some potential ongoing litigation costs.”

Steel and Tube dropped 7c to $1.48. 

“We haven't seen a really sound strategy in terms of how to address its issues, so the market remains wary of the outlook there,” says Mr Solly.

On Friday, the Commerce Commission told the Auckland High Court that Steel & Tube had tested its seismic steel mesh in its staff's lunchroom oven.

Evolve Education had its chief executive Mark Finlay announce his exit today as the the company announced a $4.2 million loss for the financial year ended March 31. The result followed two previous downgrades on forecast profit.

Its shares fell 3.33% to 58c. 

“Evolve is going through some change, the business has grown quite rapidly and now it’s coming back and having to readdress and re-evaluate where it goes,” says Mr Solly.

Orion Health lifted 2c, or 3%, to 69c ahead of its result tomorrow.

Fletcher Building climbed 13c to $6.68. Spark went up 8c to $3.64.

Rubicon fell 5.36% to 26c despite beating its target guidance with its annual profit. The forestry investor is targeting earnings approaching $US7m for the financial year ended March 2019.

Mainfreight, Orion Healthcare and Pacific Edge will release their full year results tomorrow and Tower will release its half year results.


3 · Got a question about this story? Leave it in Comments & Questions below.

This article is tagged with the following keywords. Find out more about MyNBR Tags

Post Comment

3 Comments & Questions

Commenter icon key: Subscriber Verified

Orion Healthcare and Pacific Edge reporting on the same day - woo hoo - are we going to see 2 cash issues announced?

Reply
Share
  • 1
  • 0

Dead moos at nz supermarkets oe export?

Reply
Share
  • 0
  • 0

The smart move going forward will be to take this opportunity to introduce A2 cattle onto these 'clean' farms, therefore making a good start to phasing out A1/2 protein milk.
Fonterra must admit science has proven beyond doubt that A1 protein causes many medical issues.
With large global companies such as Nestle' moving to be involved in A2 production, Fonterra must ensure the culled herd is replaced with A2 producing stock. With well in excess of 100,000 (160,000??) cattle being eradicated, this is the opportunity to begin the focus on A2 protein producing herds........ or does Fonterra just 'bury its head in the sand' as it has done for the past 12 years A2 has been on the market and medically proven.

Reply
Share
  • 0
  • 0

Post New comment or question

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.